Edition:
United Kingdom

GlycoMimetics Inc (GLYC.OQ)

GLYC.OQ on NASDAQ Stock Exchange Global Market

10.33USD
14 Dec 2018
Change (% chg)

$0.22 (+2.18%)
Prev Close
$10.11
Open
$10.06
Day's High
$10.56
Day's Low
$10.05
Volume
67,309
Avg. Vol
104,074
52-wk High
$26.05
52-wk Low
$10.05

Chart for

About

GlycoMimetics, Inc. is a clinical-stage biotechnology company. The Company focuses on the discovery and development of glycomimetic drugs. The Company operates through the identification and development of glycomimetic compounds segment. The Company is developing its lead drug candidate, GMI-1070 (Rivipansel), for the treatment... (more)

Overall

Beta: 3.18
Market Cap(Mil.): $426.05
Shares Outstanding(Mil.): 32.72
Dividend: --
Yield (%): --

Financials

  GLYC.OQ Industry Sector
P/E (TTM): -- 69.71 34.39
EPS (TTM): -1.34 -- --
ROI: -38.90 9.01 14.96
ROE: -39.26 10.15 16.52

Earnings vs. Estimates